ClinicalTrials.gg

Program

MenACYW conjugate vaccine

Its studies are mostly in Meningococcal Infections · Meningitis, Meningococcal, led by Sanofi.

Furthest: phase 4, since Jun 12, 20237 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sanofi70 open or runningphase 4since Jun 12, 2023Jun 28, 2017none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jun 28, 2017First study: phase 3 study in Meningitis, MeningococcalFirst studyNCT03205371 · 1,183 enrolled · Korea, Republic of, Mexico, Russian Federation and more
  2. Mar 19, 2018Phase 3 study in Meningococcal InfectionsNCT03476135 · 91 enrolled · Finland
  3. May 15, 20182 phase 3 studies in Meningococcal InfectionsNCT03537508, NCT03547271
  4. Jun 12, 2023Phase 4 study in Meningococcal ImmunisationNCT05929651 · 71 enrolled · Argentina
  5. Feb 22, 2024Phase 3 study in Meningococcal ImmunisationNCT06284915 · 840 enrolled · Czechia, Denmark, Finland and more
  6. Aug 14, 2025Phase 3 study in Meningococcal InfectionsNCT07135986 · 1,602 enrolled · China

TargetBeta

A vaccine: it acts on a pathogen, not a human gene.

“MenACYW conjugate vaccine”name, by rule

Studies

All 7 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07135986Meningococcal Infections · China3CompletedMay 1, 20261,602
NCT06284915Meningococcal Immunisation · Czechia, Denmark, Finland and more3CompletedNov 14, 2025840
NCT05929651Meningococcal Immunisation · Argentina4CompletedSep 9, 202471
NCT03547271Meningococcal Infections · Czechia, Finland, Italy and more3CompletedMay 17, 20231,660
NCT03537508Meningococcal Infections · United States, Puerto Rico3CompletedSep 22, 20232,627
NCT03476135Meningococcal Infections · Finland3CompletedSep 10, 201891
NCT03205371Meningitis, Meningococcal · Korea, Republic of, Mexico, Russian Federation and more3CompletedJul 19, 20181,183

How it is read

Names in the registry

  • “MenACYW conjugate vaccine”, 8 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 14, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.